首页> 外国专利> DOUBLE COMPOSITE TABLET FOR ORAL ADMINISTRATION CONTAINING TRAMADOL AND CELECOXIB

DOUBLE COMPOSITE TABLET FOR ORAL ADMINISTRATION CONTAINING TRAMADOL AND CELECOXIB

机译:含曲马多和塞来昔布的口服复合双片

摘要

The present invention relates to a double composite tablet for oral administration, comprising: a sustained release layer containing tramadol as an active ingredient; and an immediate release layer containing celecoxib as an active ingredient, wherein the double composite tablet is an oral preparation that is prescribed for alleviation of symptoms or signs of osteoarthritis (degenerative arthritis), alleviation of symptoms or sings of rheumatoid arthritis, alleviation of symptoms or signs of ankylosing spondylitis, relief of acute pain in adults (post-operative or post-extraction pain), primary dysmenorrhea, or severe and moderate acute or chronic pain. Through the present invention, a composition for pain treatment can be provided that reduces side effects of tramadol and has a continuous pain-killing effect for 12 hours by sustainedly releasing tramadol with solubility in water and immediately releasing celecoxib with poor solubility. Furthermore, the number of drugs administered is decreased by preparing two kinds of drugs into a single complex preparation, thereby improving the convenience of drug administration.
机译:本发明涉及用于口服的双重复合片剂,其包含:以曲马多为有效成分的缓释层;和含有曲马多的缓释层。含有塞来昔布作为活性成分的速释层,其中所述双重复合片剂是口服制剂,其被处方用于减轻骨关节炎(变性关节炎)的症状或体征,减轻类风湿性关节炎的症状或症状,减轻症状或减轻风湿性关节炎的症状。强直性脊柱炎的体征,成人急性疼痛的缓解(手术后或拔牙后疼痛),原发性痛经或重度和中度急性或慢性疼痛。通过本发明,通过持续释放具有水溶性的曲马多并立即释放具有不良溶解性的塞来昔布,可以提供减轻疼痛的曲马多的副作用并具有连续的12小时止痛作用的疼痛治疗用组合物。此外,通过将两种药物制成单一复合制剂来减少给药的药物数量,从而提高了给药的便利性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号